Condition: Atrial Fibrillation · Atrial Arrhythmia · Arrhythmias, Cardiac · Sponsor: Volta Medical
This PMCF study "VOLTAIRE-AF" will allow to observe acute and long-term safety and performance outcomes of the last generation of Volta Medical AI software (Volta AF-Xplorer II) during AF ablation using next-generation mapping and ablation technologies over a 24-month follow-up and in "real life"clinical practice, without any imposed clinical workflow.
This description comes directly from the study's public registry record.
Paola MILPIED · +33768025499 · paola.milpied@volta-medical.com
Cecile BIELMANN · cecile.bielmann@volta-medical.com
Always discuss trial participation with your own doctor first.
| Hôpital Saint-Joseph Marseille | Marseille, France | Recruiting |
| Centre Cardiologique du Nord | Saint-Denis, France | Not Yet Recruiting |
| Clinique Rhéna | Strasbourg, France | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07621055